Taylor H. Schreiber

发表

Immunological mechanisms of the antitumor effects of supplemental oxygenation

Akio Ohta, Shalini Sethumadhavan, A. Ohta, 2015, Science Translational Medicine.

TIGIT Checkpoint Blockade Immunity in the Setting of PD-1/PD-L1 and Myeloid Cell Activation and Antitumor LIGHT (TNFSF14) Costimulation Enhances

Thuy-Ai T Nguyen, F. Rangwala, Kellsey P. A. Johannes, 2022 .

Shining a LIGHT on myeloid cell targeted immunotherapy.

Sara R. Selitsky, S. Selitsky, T. Schreiber, 2023, European journal of cancer.

Parallel Costimulation of Effector and Regulatory T Cells by OX40, GITR, TNFRSF25, CD27, and CD137: Implications for Cancer Immunotherapy

T. Schreiber, Taylor H. Schreiber, 2016 .

CD40 Enhances Type I Interferon Responses Downstream of CD47 Blockade, Bridging Innate and Adaptive Immunity

Kellsey P. A. Johannes, Suresh de Silva, T. Schreiber, 2019, Cancer Immunology Research.

Cutting Edge: Bispecific γδ T Cell Engager Containing Heterodimeric BTN2A1 and BTN3A1 Promotes Targeted Activation of Vγ9Vδ2+ T Cells in the Presence of Costimulation by CD28 or NKG2D

A. Lai, Kellsey P. A. Johannes, T. Schreiber, 2022, The Journal of Immunology.

Shear flow-dependent integration of apical and subendothelial chemokines in T-cell transmigration: implications for locomotion and the multistep paradigm.

R. Alon, D. Cain, T. Schreiber, 2007, Blood.

Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy

Kellsey P. A. Johannes, Suresh de Silva, T. Schreiber, 2018, Journal of Immunotherapy for Cancer.

Surmounting Tumor-induced Immune Suppression by Frequent Vaccination or Immunization in the Absence of B Cells

K. Yamazaki, S. Oizumi, E. Podack, 2008, Journal of immunotherapy.

B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion

E. Podack, J. Rosenblatt, T. Schreiber, 2012, Cancer Immunology, Immunotherapy.

Reversal of IDO-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme

G. Georgiou, John Blazeck, E. Stone, 2018, Nature Biotechnology.

Secreted heat shock protein gp96-Ig: next-generation vaccines for cancer and infectious diseases

E. Podack, T. Schreiber, Taylor H. Schreiber, 2013, Immunologic research.

Secreted heat shock protein gp96-Ig: next-generation vaccines for cancer and infectious diseases

E. Podack, T. Schreiber, Taylor H. Schreiber, 2013, Immunologic Research.

T Cell Costimulation by TNFR Superfamily (TNFRSF)4 and TNFRSF25 in the Context of Vaccination

E. Podack, D. Wolf, Taylor H. Schreiber, 2012, The Journal of Immunology.

Immunobiology of TNFSF15 and TNFRSF25

E. Podack, T. Schreiber, Taylor H. Schreiber, 2013, Immunologic research.

The role of TNFRSF25:TNFSF15 in disease… and health?

E. Podack, D. Wolf, T. Schreiber, 2011, Advances in experimental medicine and biology.

Balancing Effector and Regulatory T Cell Responses in Cancer and Autoimmunity

T. Schreiber, Taylor H. Schreiber, 2010 .

Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation.

T. Malek, E. Podack, Matthew S Tsai, 2010, The Journal of clinical investigation.

Tumor-induced suppression of CTL expansion and subjugation by gp96-Ig vaccination.

E. Podack, V. Deyev, J. Rosenblatt, 2009, Cancer research.

the multistep paradigm chemokines in T-cell transmigration: implications for locomotion and dependent integration of apical and subendothelial - Shear flow

R. Alon, D. Cain, T. Schreiber, 2013 .

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Charles J. Vaske, Joe Y. Chang, Scott R. Presnell, 2016, Journal for ImmunoTherapy of Cancer.

Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer

Martin L. Miller, Chad M. Vanderbilt, Darwin Q. Ye, 2021, bioRxiv.

The Use of FoxP3 as a Biomarker and Prognostic Factor for Malignant Human Tumors

T. Schreiber, Taylor H. Schreiber, 2007, Cancer Epidemiology Biomarkers & Prevention.

Statistical Considerations in Clinical Trial Design of Immunotherapeutic Cancer Agents.

G. Acton, G. Dranitsaris, E. Podack, 2015, Journal of immunotherapy.

Heat-Shock Protein-Based Cancer Immunotherapy

T. Schreiber, Taylor H. Schreiber, 2014 .

Disruption of polycystin-L causes hippocampal and thalamocortical hyperexcitability.

D. Contreras, Jing Zhou, T. Schreiber, 2016, Human molecular genetics.

Cloning, Expression, and Functional Characterization of TL1A-Ig

E. Podack, Matthew S Tsai, V. Deyev, 2013, The Journal of Immunology.

This information is current as Characterization of TL 1 AIg Cloning , Expression , and Functional

E. Podack, Matthew S Tsai, V. Deyev, 2013 .

Tregs Expanded In Vivo by TNFRSF25 Agonists Promote Cardiac Allograft Survival

A. Tzakis, E. Podack, P. Ruiz, 2012, Transplantation.

Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection

Shalini Sethumadhavan, A. Ohta, M. Sitkovsky, 2014, Journal of Molecular Medicine.

The Role of B Cells in Shaping the Antitumor Immune Response

J. Rosenblatt, T. Schreiber, Yu Zhang, 2014 .

Host CD4+CD25+ T cells can expand and comprise a major component of the Treg compartment after experimental HCT.

T. Malek, A. Bayer, R. Levy, 2009, Blood.

A critical analysis of the tumour immunosurveillance controversy for 3-MCA-induced sarcomas

E. Podack, T. Schreiber, Taylor H. Schreiber, 2009, British Journal of Cancer.